Integra LifeSciences
IART
279 hedge funds and large institutions have $4.12B invested in Integra LifeSciences in 2019 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 104 increasing their positions, 82 reducing their positions, and 38 closing their positions.
28,659% more call options, than puts
Call options by funds: $4.89M | Put options by funds: $17K
27% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 82
16% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 38
1.37% more ownership
Funds ownership: 80.93% → 82.3% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less funds holding
Funds holding: 280 → 279 (-1)
1% less capital invested
Capital invested by funds: $4.16B → $4.12B (-$40M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$105M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$64.7M |
| 3 |
Goldman Sachs
New York
|
+$23.4M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$23.1M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$15.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$64.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$33.1M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$23.6M |
| 4 |
CBT
Capital Bank & Trust
Irvine,
California
|
-$12.9M |
| 5 |
Millennium Management
New York
|
-$12M |
IART Hedge Fund Activity: Q4 2019 in Review
279 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2019, worth a combined $4.12B — down 0.96% from $4.16B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new IART positions and 38 closed out — a net gain of 6 holders — while 104 added to existing stakes and 82 trimmed.
The largest buyer was Cooke & Bieler, opening a new position worth an estimated $105M. The largest seller was Invesco, cutting an estimated $64.9M.
- 279 institutional investors held Integra LifeSciences (IART) as of Q4 2019, down from 280 in Q3 2019.
- Funds reported $4.12B of Integra LifeSciences stock for Q4 2019, down 0.96% quarter-over-quarter.
- 44 funds opened new Integra LifeSciences positions in Q4 2019 and 38 closed out, a net change of +6 holders.
- The largest Integra LifeSciences buyer in Q4 2019 was Cooke & Bieler, an estimated $105M added.
- The largest Integra LifeSciences seller in Q4 2019 was Invesco, an estimated $64.9M sold.
Based on aggregated 13F filings for Q4 2019.